Quantcast

Latest Blood Cancer Stories

2014-02-12 16:26:29

CLL is second indication approved by FDA for ibrutinib; previously approved for mantle cell lymphoma patients WHITE PLAINS, N.Y., Feb. 12, 2014 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with chronic lymphocytic leukemia (CLL) is a significant advance for patients with this blood cancer. Ibrutinib received FDA approval in November to treat patients with mantle cell lymphoma (MCL) who had previously been treated with one...

2014-02-11 12:27:34

WHITE PLAINS, N.Y., Feb. 11, 2014 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today announced that John Walter, who has served as president and chief executive officer of the organization since 2008, has stepped down. Louis J. DeGennaro, Ph.D., has been named interim president and CEO while the board of directors considers a permanent replacement. Dr. DeGennaro has been serving as LLS executive vice president and chief mission officer. Walter will consult with LLS...

2014-02-08 23:03:46

Kurt Jacquin, Owner of SuperSlow Zone in San Antonio, TX is proud to support the Leukemia and Lymphoma Society, a not-for-profit organization dedicated to funding blood cancer research and providing education and patient services. San Antonio, TX (PRWEB) February 08, 2014 Kurt Jacquin, Owner of SuperSlow Zone in San Antonio, TX is proud to support the Leukemia and Lymphoma Society, a not-for-profit organization dedicated to funding blood cancer research and providing education and patient...

2014-01-23 16:24:44

Grant Program Addresses Three Critical Areas of Blood Cancer Research WHITE PLAINS, N.Y., Jan. 23, 2014 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today is pleased to announce the fourteen researchers who will receive funding through the Quest for Cures program - a new grant program that addresses three critical areas of blood cancer research. The three priority areas are: monitoring tumor cell heterogeneity and its contribution to response or resistance to therapy; molecular...

2014-01-22 12:26:50

The top national LLS partner helping to make Someday, Today, for blood cancer WHITE PLAINS, N.Y., Jan. 22, 2014 /PRNewswire/ -- For the 12(th) consecutive year, Burlington joined The Leukemia & Lymphoma Society's (LLS) Light The Night® campaign to raise funds to help find cures and ensure access treatments for patients with blood cancer by encouraging customers to make a donation at check-out. Over the 17 week campaign hosted from July through October 2013, Burlington raised...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related